Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
FDA Hearing on the Center for Drug Evaluation and Research’s proposal to withdraw approval of Makena occurring on October 17-19, 2022
Featured Topics
FDA Monkeypox Response
The FDA’s multipronged response to monkeypox includes efforts in the areas of diagnostics, vaccines and therapeutics.
Infant Formula Information and Resources
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Oct 24
Whele LLC Announces National Voluntary Recall of Mighty Bliss Electric Heating Pad Due to Product Safety Concerns
Medical Devices
Oct 23
Seed Ranch Flavor Co Issues Allergy Alert on Undeclared Soy in "Umami Everyday Sauce" and “Everything But The Sushi & Dumplings” Sauce
Food & Beverages
Oct 21
Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System
Medical Devices
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Seeks Feedback on Distributed and Point-of-Care Drug Manufacturing
These technologies could potentially provide flexibility for drug manufacturers to increase timely access to quality drugs.
FDA Releases New, Prevention Strategies to Enhance Food Safety
The strategies contain recommendations to guide the work of preventing future foodborne illnesses.
FDA Takes Steps to Further Harmonize Clinical Research Regulations with HHS Common Rule
FDA is working to make clinical trials more efficient and improve information for potential participants.